Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Nov 12, 2024 1:00 PM - Nov 14, 2024 5:30 PM

(Central Europe Standard Time)

Risk Minimisation Measures

In this course, we will share experiences and challenges in designing, implementing, and evaluating RMMs in different regulatory settings and different therapeutic areas.

Continuing Education

All DIA training courses have been awarded a PharmaTrain Centre Recognition.





PharmaTrain Federation is a not for profit organisation that started its activities as an IMI (Innovative Medicines Initiative) European Project. Its mission is to drive implementation of globally recognized high-level standards for postgraduate education and training in Medicines Development. To that aim, the Federation is assessing Continuous Professional Development (CPD) Courses and Course Providers around the world that deserve recognition.


The Swiss Association of Pharmaceutical Professionals (SwAPP) and the Swiss Society for Pharmaceutical Medicine (SGPM) have accredited this training course with 11,50 credits.
Special rates available for SwAPP and SGPM members.

NameCredit TypeMax CreditsCEU
Risk Minimisation Measures, 12-14 Nov 2024, 13:00-17:30 CET, Virtual EventCredit TypeSWAPP/SGPMMax Credits11.50CEU0.000

Statement of Credit:

Please note: Most EU countries accept direct submission, by the participant, of training courses, conferences and other educational opportunities with the aim of obtaining CPD (Continuous Professional Development) points. Please do not hesitate to contact DIA directly if you need any further documentation (e.g. detailed program, certificate of completion, etc.) to conclude your submission.

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.